Skip to main content

News Releases

Menu
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
December 19, 2017
Rucaparib MAA for the Ovarian Cancer Treatment Indication Referred by CHMP to Scientific Advisory Group on Oncology for Review Expected in February 2018 Download PDF format download (opens in new window)
December 5, 2017
Clovis Announces Priority Review Designation for Rucaparib Supplemental New Drug Application Download PDF format download (opens in new window)
November 8, 2017
Clovis Oncology to Present at the Stifel 2017 Healthcare Conference Download PDF format download (opens in new window)
November 1, 2017
Clovis Oncology Announces Third Quarter 2017 Operating Results Download PDF format download (opens in new window)
October 23, 2017
Clovis Oncology to Announce Third Quarter 2017 Financial Results and Host Webcast Conference Call on November 1 Download PDF format download (opens in new window)
October 9, 2017
Clovis Oncology Submits Supplemental New Drug Application for Rucaparib as Maintenance Treatment for Patients with Platinum-Sensitive Recurrent Ovarian Cancer Download PDF format download (opens in new window)
September 13, 2017
Clovis Oncology’s Rucaparib ARIEL3 Study Data Published in The Lancet Download PDF format download (opens in new window)
September 7, 2017
Clovis Oncology Presents Comprehensive Dataset from Successful Phase 3 ARIEL3 Maintenance Treatment Trial of Rucaparib in Advanced Ovarian Cancer at ESMO 2017 Download PDF format download (opens in new window)
August 30, 2017
Clovis Oncology to Present Comprehensive Dataset from Successful ARIEL3 Clinical Trial Program at 2017 ESMO Congress Download PDF format download (opens in new window)
August 2, 2017
Clovis Oncology Announces Second Quarter 2017 Operating Results Download PDF format download (opens in new window)
July 31, 2017
Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration to Evaluate Combination of Opdivo® (Nivolumab) and Rubraca® (Rucaparib) in Phase 2 and Pivotal Phase 3 Clinical Trials in Multiple Tumor Types Download PDF format download (opens in new window)
July 19, 2017
Clovis Oncology to Announce Second Quarter 2017 Financial Results and Host Webcast Conference Call on August 2 Download PDF format download (opens in new window)
June 21, 2017
Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock Download PDF format download (opens in new window)
June 20, 2017
Clovis Oncology Announces Upsizing and Pricing of Public Offering of Common Stock Download PDF format download (opens in new window)
June 19, 2017
Clovis Oncology Announces Proposed Offering of Common Stock Download PDF format download (opens in new window)
June 19, 2017
Clovis Oncology’s Rucaparib Significantly Improved Progression-Free Survival in All Ovarian Cancer Patient Populations Studied in Phase 3 ARIEL3 Maintenance Treatment Trial Download PDF format download (opens in new window)
May 23, 2017
Clovis Oncology Announces Presentations at 2017 ASCO Annual Meeting Download PDF format download (opens in new window)
May 3, 2017
Clovis Oncology Announces First Quarter 2017 Operating Results Download PDF format download (opens in new window)
April 27, 2017
Myriad Genetics and Clovis Oncology Sign Agreement for Use of FDA-Approved BRACAnalysis CDx® Test to Identify Patients with Germline BRCA Mutations for Rubraca® (rucaparib) Treatment Download PDF format download (opens in new window)
April 20, 2017
Clovis Oncology to Announce First Quarter 2017 Financial Results and Host Webcast Conference Call on May 3 Download PDF format download (opens in new window)
March 28, 2017
Clovis Oncology Announces Data Presentations at AACR Annual Meeting 2017 Download PDF format download (opens in new window)
March 12, 2017
Clovis Oncology Presents New Data from Phase 2 Studies of Rucaparib in Advanced Ovarian Cancer at 2017 SGO Annual Meeting on Women’s Cancer Download PDF format download (opens in new window)
February 22, 2017
Clovis Oncology Announces 2016 Operating Results Download PDF format download (opens in new window)
February 9, 2017
Clovis Oncology to Announce Fourth Quarter/Year-End 2016 Financial Results and Host Webcast Conference Call on February 22 Download PDF format download (opens in new window)
February 1, 2017
Clovis Oncology and Strata Oncology Announce Collaboration to Accelerate Enrollment in Rucaparib Prostate Cancer Development Program Download PDF format download (opens in new window)
January 9, 2017
Clovis Oncology to Present at the 35th Annual J.P. Morgan Healthcare Conference Download PDF format download (opens in new window)
January 4, 2017
Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock Download PDF format download (opens in new window)
January 3, 2017
Clovis Oncology Announces Upsizing and Pricing of Public Offering of Common Stock Download PDF format download (opens in new window)
January 3, 2017
Clovis Oncology Announces Proposed Offering of Common Stock Download PDF format download (opens in new window)